Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Epstein

Showing results (61-70 of 1,864) with videos related to

Pageof 187
Sort By:
The Medical Journal of Australia|February 1, 1993
Morbidity and treatment in general practice in Australia 1990-1991M Epstein
Cardiovascular Drugs and Therapy|January 1, 1997
Calcium channel blockers and hypertension: evolving perspective--1996M Epstein
Physiological Reviews|July 1, 1978
Renal effects of head-out water immersion in man: implications for an understanding of volume homeostasisM Epstein
The American Journal of Medicine|January 17, 1986
Renal prostaglandins and the control of renal function in liver diseaseM Epstein
The New England Journal of Medicine|December 14, 1989
Treatment of refractory ascitesM Epstein
Clinical Symposia (Summit, N.J. : 1957)|January 1, 1985
Renal complications of liver diseaseM Epstein
Hepatology (Baltimore, Md.)|March 1, 1986
The sodium retention of cirrhosis: a reappraisalM Epstein
Acta Diabetologica|September 12, 2002
Evolving therapeutic strategies for retarding progression of diabetic nephropathy--an update for 2002M Epstein
Journal of Hypertension|June 8, 2001
Aldosterone and the hypertensive kidney: its emerging role as a mediator of progressive renal dysfunction: a paradigm shiftM Epstein
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 29, 2001
Aldosterone as a mediator of progressive renal disease: pathogenetic and clinical implicationsM Epstein
Pageof 187

Showing results (61-70 of 1,864) with videos related to

Sort By:
Pageof 187
The Medical Journal of Australia|February 1, 1993
Morbidity and treatment in general practice in Australia 1990-1991M Epstein
Cardiovascular Drugs and Therapy|January 1, 1997
Calcium channel blockers and hypertension: evolving perspective--1996M Epstein
Physiological Reviews|July 1, 1978
Renal effects of head-out water immersion in man: implications for an understanding of volume homeostasisM Epstein
The American Journal of Medicine|January 17, 1986
Renal prostaglandins and the control of renal function in liver diseaseM Epstein
The New England Journal of Medicine|December 14, 1989
Treatment of refractory ascitesM Epstein
Clinical Symposia (Summit, N.J. : 1957)|January 1, 1985
Renal complications of liver diseaseM Epstein
Hepatology (Baltimore, Md.)|March 1, 1986
The sodium retention of cirrhosis: a reappraisalM Epstein
Acta Diabetologica|September 12, 2002
Evolving therapeutic strategies for retarding progression of diabetic nephropathy--an update for 2002M Epstein
Journal of Hypertension|June 8, 2001
Aldosterone and the hypertensive kidney: its emerging role as a mediator of progressive renal dysfunction: a paradigm shiftM Epstein
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 29, 2001
Aldosterone as a mediator of progressive renal disease: pathogenetic and clinical implicationsM Epstein
Pageof 187